Richard Barry, Director at Sarepta Therapeutics, Inc. (SRPT), sold 60,000 shares at $158.43 ($9.5M) on 2020-08-07, disclosed to the SEC on 2020-08-07.
Open-market sale of $9.5M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.43 | 26,860 | $4.3M | 44.7% |
| 2 | $158.43 | 26,860 | $4.3M | 44.7% |
| 3 | $159.09 | 3,140 | $500K | 5.3% |
| 4 | $159.09 | 3,140 | $500K | 5.3% |
| Total | $158.50 avg | 60,000 | $9.5M | 100% |
| Filing → |
| SAVA | BUY | 2025-11-24 | $828K | — | Filing → |
| SAVA | BUY | 2025-11-20 | $404K | — | Filing → |
| SAVA | BUY | 2025-09-23 | $16K | — | Filing → |